Partnership
Co-development & Licensing
RDPI platform
RDPI® is a scalable platform, with application across drug classes and formulations. This creates broad potential for pipeline development and strategic partnership.
​
Through collaboration with various organizations, our advancements can positively impact a greater number of individuals, enhancing their quality of life in a more advanced manner and broad innovative solutions to next scale.
​
With expertise ranging from developing and refining ideas to exploring worldwide licensing partners for RDPI Product® we possess the ability to establish partnerships that have the potential to cultivate a limitless world for everyone.
​
We strongly believe in gathering ideas, talents and technology for a better future.
PARTNERING MODELS
Generic Route
APIs already approved for inhalation
Lead Development:
INHALED THERAPEUTICS
Income:
Regional-Local Licenses
Regulatory pathway:
Bioequivalence / Low risk
NTE + Inhaled Route
APIs approved by other routes
Lead Development:
INHALED THERAPEUTICS
Income:
Global Licenses
Regulatory pathway:
Local tolerance / Mid-risk
NCE + Inhaled Route
APIs not approved yet
Lead Development:
PARTNERSHIPS
Income:
Royalties
Regulatory pathway:
Full development program / High risk